ArticleGenes & genomics2025
NPR1 modulates DNA replication in vascular endothelial cells via the transcription factor E2F2.
Article in Genes & genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundNatriuretic peptide receptor 1 (NPR1) plays a crucial role in maintaining the functionality of vascular endothelial cells. However, its role in regulating DNA replication and genome stability in endothelial cells remains unexplored.
objectiveThis study aimed to investigate whether NPR1 deficiency disrupts DNA replication and induces DNA damage in human umbilical vein endothelial cells (HUVECs), and to explore the mechanistic role of the E2F transcription factor 2 (E2F2) in this process.
methodsRNA-sequencing analysis was performed in NPR1-deficient HUVECs. EdU incorporation assay quantified DNA replication activity. qPCR or RNA-seq evaluated expression of DNA replication-related genes. DNA damage levels were assessed via phosphorylated histone H2AX (γH2AX). The proteins of NPR1, E2F2 and γH2AX were examined by Western blot. E2F2 was knocked down or overexpressed in NPR1-deficient HUVECs to validate its regulatory role.
resultsDNA replication related genes were downregulated in NPR1-knockdown HUVECs. This result was supported by a decrease of EdU positive rate of HUVECs upon NPR1 deficiency. Downregulation of DNA replication genes (DSCC1, EXO1, MCM4, MCM6, TREX1 and CCNE2) was observed in NPR1-deficient cells. NPR1 knockdown increased γH2AX, particularly in EdU-positive cells. NPR1 silencing reduced the expression of E2F2. E2F2 knockdown mimicked NPR1 deficiency, suppressing DNA replication genes and increasing DNA damage. Additionally, overexpression of E2F2 recovered the DNA replication and mitigated DNA damage in NPR1-knockdown HUVECs.
conclusionsNPR1 deficiency declines DNA replication activity and induces DNA damage in vascular endothelial cell by inhibiting E2F2 expression. This provides further insights into the underlying mechanism on NPR1 in the regulation of the functionality of vascular endothelial cells.
Indexed as
Identifiers
41071534What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.